Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature

Journal of Neurology, Neurosurgery, and Psychiatry
Luana BenedettiDario Cocito

Abstract

A few case reports have shown controversial results of rituximab efficacy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). To analyse the efficacy of rituximab in a large CIDP cohort. A retrospective, observational and multicentre study on the use of rituximab in CIDP. 13 Italian CIDP patients were treated with rituximab after the partial or complete lack of efficacy of conventional therapies. Eight patients had co-occurring haematological diseases. Patients who improved by at least two points in standard clinical scales, or who reduced or discontinued the pre-rituximab therapies, were considered as responders. Nine patients (seven with haematological diseases) responded to rituximab: six of them, who were non-responders to conventional therapies, improved clinically, and the other three maintained the improvement that they usually achieved with intravenous immunoglobulin or plasma exchange. Significantly associated with shorter disease duration, rituximab responses started after a median period of 2.0 months (range, 1-6) and lasted for a median period of 1 year (range, 1-5). Rituximab seems to be a promising therapeutic choice when it targets both CIDP and co-occurring haematolog...Continue Reading

Citations

Jan 19, 2011·Current Treatment Options in Neurology·Glenn Lopate, Alan Pestronk
Aug 9, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Min-Suk YoonRalf Gold
Nov 10, 2012·Therapeutic Advances in Neurological Disorders·Kenneth C Gorson
Sep 10, 2014·Revue neurologique·R Guimarães-CostaJ-M Léger
Mar 22, 2013·Drugs·Eduardo Nobile-Orazio, Francesca Gallia
Apr 9, 2013·Current Treatment Options in Neurology·Mazen M Dimachkie, Richard J Barohn
Mar 24, 2016·Journal of the Neurological Sciences·A CorteseE Marchioni
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Marc LégerCristina Muntean
May 7, 2013·La Presse médicale·Marinos C Dalakas
Jan 23, 2013·Journal of the Neurological Sciences·Joerg-Patrick Stübgen
May 7, 2013·Neurologic Clinics·Kenneth C Gorson, Jonathan Katz
Oct 31, 2012·Revue neurologique·T Kuntzer
Jun 23, 2011·Journal of the Peripheral Nervous System : JPNS·Hans-Peter HartungRichard A C Hughes
Nov 25, 2014·Muscle & Nerve·Melvin Berger, Jeffrey A Allen
Jun 25, 2015·Neurodegenerative Disease Management·Yusuf A RajaballyHans D Katzberg
May 27, 2015·Current Neurology and Neuroscience Reports·Inna Kleyman, Thomas H Brannagan
Nov 14, 2012·Journal of the Neurological Sciences·Emily K Mathey, John D Pollard
Jun 21, 2014·Biochimica Et Biophysica Acta·Marinos C Dalakas
Jun 10, 2017·Expert Review of Neurotherapeutics·Eduardo Nobile-OrazioMariangela Bianco
Sep 12, 2018·Journal of the Peripheral Nervous System : JPNS·Thomas RouxKarine Viala
Dec 1, 2018·Practical Neurology·Daniel H WhittamAnu Jacob
Aug 17, 2011·Nature Reviews. Neurology·Marinos C Dalakas, UNKNOWN Medscape
Sep 16, 2017·Nature Reviews. Neurology·Yusuf A RajaballyRayaz A Malik
May 11, 2012·Journal of the Peripheral Nervous System : JPNS·Marinos C Dalakas
Apr 18, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Helmar Christoph LehmannSatoshi Kuwabara
Jul 26, 2017·Internal Medicine Journal·Sarah WongseelashotePeter Francis Bourke
Jan 11, 2020·Muscle & Nerve·Suraj A MuleyMazen M Dimachkie
Feb 13, 2018·Neurology. Clinical Practice·Salvatore SavastaEnrico Marchioni
Aug 10, 2011·Current Opinion in Neurology·Josef FinstererMichaela Auer-Grumbach
Oct 2, 2020·Continuum : Lifelong Learning in Neurology·Kelly Gwathmey
Apr 7, 2017·Therapeutic Advances in Neurological Disorders·Gisa EllrichmannChristiane Schneider-Gold
Oct 10, 2018·Current Opinion in Allergy and Clinical Immunology·Emma C TallantyreStephen Jolles
Aug 25, 2017·Journal of Neurology·Kalliopi PitarokoiliChristiane Schneider-Gold
Jan 9, 2021·Journal of Neurology·Clara Grazia ChisariFrancesco Patti
Jan 17, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Chiara BrianiEduardo Nobile-Orazio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved